| Date | Title | Description | Source |
| 08.11.2023 | Ascidian Therapeutics Raises $40 Million in Series A Extensi... | Funds from ATP will support the progress of Ascidian’s lead program in ABCA4 retinopathies, includin... | appletreep... |
| 08.11.2023 | Ascidian Therapeutics Raises $40 Million in Series A Extensi... | Funds from ATP will support the progress of Ascidian’s lead program in ABCA4 retinopathies, includin... | appletreep... |
| 08.11.2023 | Ascidian Therapeutics Scores $40M in Series A Extension |
BOSTON, MA, Ascidian Therapeutics, a biotechnology company, announced $40 million in Series A exte... | vcnewsdail... |
| 08.11.2023 | Ascidian Therapeutics Raises $40 Million in Series A Extensi... | Funds from ATP will support the progress of Ascidian’s lead program in ABCA4 retinopathies, includin... | appletreep... |
| 08.11.2023 | Ascidian Therapeutics Raises $40M in Series A Extension Fina... | Ascidian Therapeutics, a Boston, MA-based biotechnology company focused on treating human diseases b... | finsmes.co... |
| 13.10.2022 | Ascidian Therapeutics Raises $50M in Series A Funding | Ascidian Therapeutics, a Boston, MA-based biotechnology company, raised $50M in Series A funding.
T... | finsmes.co... |
| 12.10.2022 | Ascidian Therapeutics Launches to Rewrite RNA | ATP incubated and built Ascidian with $50 million in Series A funding
Pioneering RNA exon editing p... | appletreep... |
| 12.10.2022 | Ascidian Therapeutics Launches to Rewrite RNA | ATP incubated and built Ascidian with $50 million in Series A funding
Pioneering RNA exon editing p... | appletreep... |
| - | Ascidian Therapeutics | “Ascidian is redefining the treatment of disease by rewriting RNA.” | fastfounde... |
